INVO Fertility (IVF) Revenue Growth (1y) (2012 - 2025)
INVO Fertility (IVF) Revenue Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 7.41% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 7.29% |
| 10 | INVO Fertility | 4.48 Mn | 4.13 Mn | 629,345.00 | 22.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 1.47% |
| Mar 31, 2025 | 3.86% |
| Dec 31, 2024 | 22.02% |
| Sep 30, 2024 | 47.01% |
| Jun 30, 2024 | 481.38% |
| Mar 31, 2024 | 352.92% |
| Dec 31, 2023 | 396.78% |
| Sep 30, 2023 | 314.28% |
| Jun 30, 2023 | 116.17% |
| Mar 31, 2023 | 114.04% |
| Dec 31, 2022 | -90.88% |
| Sep 30, 2022 | 7.51% |
| Jun 30, 2022 | -29.90% |
| Mar 31, 2022 | -76.25% |
| Dec 31, 2021 | 1,450.70% |
| Sep 30, 2021 | -34.87% |
| Jun 30, 2021 | -15.28% |
| Mar 31, 2021 | 164.73% |
| Dec 31, 2020 | -40.17% |